Cancer cells frequently evade apoptosis during tumorigenesis by acquiring mutations in apoptotic regulators. Chronic activation of the PI 3-kinase-Akt pathway through loss of the tumor suppressor PTEN is one mechanism by which these cells can gain increased protection against apoptosis. We report here that REDD1 (RTP801) can act as a transcriptional downstream target of PI 3-kinase signaling in human prostate cancer cells (PC-3). REDD1 expression is markedly reduced in PC-3 cells treated with LY294002 (LY) or Rapamycin and strongly induced under hypoxic conditions in a hypoxiainducible factor-1 (HIF-1)-dependent manner. Loss of function studies employing antisense molecules or RNA interference indicate that REDD1 is essential for invasive growth of prostate cancer cells in vitro and in vivo. Reduced REDD1 levels can sensitize cells towards apoptosis, whereas elevated levels of REDD1 induced by hypoxia or overexpression desensitize cells to apoptotic stimuli. Taken together our data designate REDD1 as a novel target for therapeutic intervention in prostate cancer.
Introduction
Tumorigenesis is frequently accompanied by mutations in apoptotic regulators (Hanahan and Weinberg, 2000) . Activation of the phosphatidylinositol (PI) 3-kinaseAkt signaling pathway can contribute to the increased resistance of tumor cells to apoptosis (Coffer et al., 1998) . The tumor suppressor PTEN dephosphorylates the PI 3-kinase phospholipid products and thereby ensures that the activation of the PI 3-kinase pathway occurs in a transient and controlled manner. Consequently, loss of PTEN function leads to chronic activation of PI 3-kinase and its downstream effectors such as the kinase Akt (Cantley and Neel, 1999; Vazquez and Sellers, 2000) . PTEN loss of function mutations are a characteristic of many cancers showing increased resistance towards apoptotic stimuli (Di Cristofano and Pandolfi, 2000; Simpson and Parsons, 2001) . Hence, the identification of PI 3-kinase-dependent, antiapoptotic effector molecules should lead to novel therapeutics. For the discovery of genes that regulate the malignant growth of cells with a chronically active PI 3-kinase pathway, such as PTEN À/À cells, we compared the gene expression profile between cells, in which PI 3-kinase was switched on versus cells in which it was turned off (for details see Kaufmann et al., 2004) .
Overexpression of hypoxia-inducible factor (HIF)-1a is also a frequent event in many human cancers (Zhong et al., 1999; Bottaro and Liotta, 2003) and chronic activation of the PI 3-kinase/Akt pathway has been reported to enhance HIF-1a-activated responses (Jiang et al., 2001; Harris, 2002) . HIF-1a is one of two subunits of the HIF-1 transcription factor, the cellular sensor for oxygen tension. HIF-1b (also known as aryl hydrocarbon receptor nuclear translocator -ARNT) is constitutively expressed, while HIF-1a is rapidly degraded under normoxic conditions. Hypoxia stabilizes HIF-1a so that HIF-1-dependent transcription is activated (Poellinger and Johnson, 2004) . Reduced oxygen tension represents an apoptotic stimulus that occurs during formation of a solid tumor and is considered being one major factor contributing to the malignant phenotype. Although prolonged hypoxia is detrimental, cancer cells adapt to survive under hypoxic conditions and are thus selected to become more resistant to therapy (Harris, 2002) . Accordingly, high levels of tumor hypoxia are associated with a poor prognosis in several cancers (Hockel and Vaupel, 2001 ). HIF-1 has a dual role in response to hypoxia, in that it mediates hypoxia-induced cell death (Carmeliet et al., 1998) as well as antiapoptotic responses including the expression of several survival genes and angiogenic factors (e.g. VEGF) (Zaman et al., 1999; Baek et al., 2000) . Studies on tumor progression with HIF1-a knockout tumors in wild-type mice revealed both reduced and faster growth dependent on the specific microenvironment (Blouw et al., 2003) .
REDD1 (for Regulated in Development and DNA damage responses) also referred to as RTP801 has been described as a transcriptional target of HIF-1a by Shoshani et al. (2002) . Furthermore, the study by (Ellisen et al., 2002) has identified REDD1 as a p53-dependent DNA damage response gene and as a p63-dependent gene involved in epithelial differentiation. We report here that REDD1 can act as a shared effector of PI 3-kinase/HIF-1 signaling in human prostate cancer cells. The expression of REDD1 and its upregulation in response to hypoxic culture conditions is dependent upon PI 3-kinase and HIF-1a. REDD1 expression is reduced in response to apoptotic stimuli. Induction of REDD1 by hypoxic preconditioning or overexpression of REDD1 desensitizes cells to apoptotic stimuli. This protective effect of hypoxia can be overcome by reduction of either HIF-1a or REDD1 expression, thereby implying REDD1 as an essential mediator of the antiapoptotic role of HIF-1.
Results

REDD1 expression is dependent on PI 3-kinase signaling
Our initial objective was to identify novel transcriptional downstream targets in the PI 3-kinase pathway and to test whether these genes are required for PI 3-kinasedependent invasive growth of prostate cancer cells . Several studies have demonstrated that growth in 3D cultures using extracellular matrix containing basement membrane (matrigel) represents a surrogate assay for the malignant potential of tumor cells (for a review, see Schmeichel and Bissell, 2003) . We have shown previously that treatment of PTEN À/À PC-3 cells (human prostate cancer cells) with the PI 3-kinase inhibitor LY led to a dramatic growth inhibition on matrigel (Czauderna et al., 2003a; Kaufmann et al., 2004) . Similarly, reduction of PC-3 cell growth on matrigel can be achieved with Rapamycin treatment, a drug known to inhibit the PI 3-kinase downstream effector mTOR ( Figure 1a ). We used these pharmacological inhibitors in combination with the matrigel-based 3D culture system for gene expression profiling (Affymetrix) and identified REDD1 (RTP801) mRNA to be significantly downregulated in response to LY and Rapamycin treatment in PC-3 cells (Table 1) . REDD1 mRNA was represented by three different probe sets on the DNA chip (Affymetrix) and the downregulation was consistent in each of them. The mRNA of VEGF, a known PI 3-kinase/HIF-1-dependent target gene, was also reduced in Rapamycin-or LY-treated cells relative to the DMSO control samples. Relative ratios of the mRNA signals for the two catalytic PI 3-kinase subunits, p110a and p110b, the downstream kinases Akt 1/2 and HIF-1a remained unaffected and are shown for control (Table 1) . To verify the DNA chip analysis, we performed real-time PCR on RNA derived from different time points after LY treatment. A strong downregulation of REDD1 mRNA beginning at 4 h post LY treatment was observed (Figure 1b) . Interestingly, we also detected a twofold increase of REDD1 mRNA over time in the DMSO vehicle-treated cells. In order to confirm the differential expression of REDD1 on protein level, we generated a polyclonal antiserum against full-length REDD1. Both the time-dependent upregulation of REDD1 in growing PC-3 cells and the downregulation of REDD1 expression by PI 3-kinase inhibitors could be verified on the level of protein expression as well (Figure 1c ). REDD1(RTP801) mRNA has been found to be p53 dependently induced following DNA damage, p63 dependently during embryogenesis and epithelial differentiation (Ellisen et al., 2002) , and also HIF-1 dependently in response to hypoxia (Shoshani et al., 2002) . Since PC-3 cells are negative for p53 and p63 (data not shown and Figure 3a) , we hypothesized that the increase in REDD1 expression observed here is a consequence of increasing hypoxic conditions over time according to growing density in tissue culture (Sheta et al., 2001; Chrastina, 2003) . Indeed, immunoblot analysis of HIF-1a expression revealed a slight elevation of HIF-1a protein in growing PC-3 cells, but this HIF1a induction did not appear to be influenced by reduced PI 3-kinase activity due to LY treatment ( Figure 1c , compare lanes 7 and 8).
REDD1 is induced under hypoxic conditions in a PI 3-kinase-dependent manner
To prove the hypoxia-dependent expression of REDD1, we activated the hypoxic response in PC-3 cells by treatment with CoCl 2 (Salnikow et al., 2000; Ivan et al., 2001) . This activation can be reversed by addition of CdCl 2 (Chun et al., 2000) . As expected, REDD1 and HIF-1a expression were significantly induced in PC-3 cells treated with CoCl 2 and this induction could be efficiently blocked by addition of CdCl 2 or by inhibition of PI 3-kinase activity using LY (Figure 2a and b) . The level of HIF-1a protein in LY-pretreated cells compared to the HIF-1a level in DMSO-pretreated cells decreased to some extent at the later time point as well (Figure 2b , lanes 3 and 4). However, the effect of PI 3-kinase inhibition on REDD1 was much more prominent than the effect on HIF-1a. Hypoxia-dependent induction of REDD1 is in agreement with the recently reported hypoxia-dependent REDD1 (RTP801) mRNA expression in a rat model for stroke (Shoshani et al., 2002) . Immunostaining on human prostate cancer tissue revealed a significant expression of REDD1 protein (Figure 2c ), which is consistent with the proposed hypoxic microenvironment in some malignant tissue in vivo (Harris, 2002) . In a next step, we wanted to analyse the consequences of inhibition of the catalytic subunits of PI 3-kinase (Vanhaesebroeck and Waterfield, 1999) on REDD1 expression employing post-transcriptional gene silencing tools including third generation antisense technology (GB, GeneBloct, Sternberger et al., 2002) . We generated GB molecules specific for the two catalytic PI 3-kinase subunits, p110a and p110b. To control for specificity, we used inactive antisense molecules with 4 mismatches (MM). PC-3 cells transfected with p110b-, but not p110a-, specific antisense molecules showed a reduction of Akt phosphorylation comparable to that achieved by treatment with LY ( Figure 2d, lanes 3 and 5). This inhibition was accompanied by a marked reduction of REDD1 again demonstrating PI 3-kinasedependent expression. We have reported previously that knockdown of one of the PI 3-kinase catalytic subunits, in PC-3 cells the p110b isoform, is sufficient for a substantial reduction in phosphorylation of the downstream effector Akt (Czauderna et al., 2003a; Leenders et al., 2004) . As expected, transfection of Akt1-and Akt2-specific GBs into PC-3 cells resulted in a substantial decrease of REDD1 expression as well with CoCl 2 (100 mM) and CdCl 2 (100 mM). Cells were seeded and grown overnight before salt solutions were added. Cells were lysed after the indicated time periods and subjected to immunoblot analysis of protein expression of p110a, p85, HIF-1a, REDD1 and HSP60. (b) Induction of hypoxic response in PC-3 cells pretreated with PI 3-kinase inhibitor LY. PC-3 cells grown overnight were pretreated with LY (10mM) or DMSO as solvent control. After 24 h, CoCl 2 (100 mM) was added. Cells were harvested 24 and 48 h after CoCl 2 addition and subjected to immunoblot analysis. (c) Immunohistochemical staining of adjacent slides of prostate tumor samples with anti-REDD1-antiserum (1 : 5000) or preimmune serum. (d) PC-3 cells grown overnight were transfected with GBs specific for the catalytic subunits of PI 3-kinase p110a or p110b or with corresponding mismatch molecules (60 nM GB). Additional samples were treated with LY, DMSO or left untreated. Cells were harvested 72 h later and lysates were subjected to immunoblot analysis. (e) PC-3 cells grown overnight were transfected with GBs specific for Akt1 or Akt2, single or in combination, or with corresponding mismatch molecules (60 nM GB each). Cells were harvested 72 h later and lysates were subjected to immunoblot analysis. (f) PC-3 cells grown overnight were transfected with GBs specific for HIF-1a or with corresponding mismatch molecules (60 nM GB), 24 h later CoCl 2 was added. Cells were harvested 24 h after induction of hypoxic response and protein expression was analysed Figure 2e ). We concluded from these data that REDD1 expression is in PC-3 cells dependent on the function of the PI 3-kinase effector Akt as well. In a similar approach, untreated cells and cells transfected with GBs specific for HIF-1a or the respective mismatch molecules were subjected to CoCl 2 treatment for 24 h (Figure 2f ). The hypoxia-dependent upregulation of REDD1 in PC-3 cells could be blocked completely by GB-mediated inhibition of HIF-1a, demonstrating the HIF-1a-dependent expression of REDD1 in hypoxic PC-3 cells.
Hypoxic induction of REDD1 does not depend on the p63 status of the cell
Since REDD1 has also been described as a transcriptional target of p63 in primary keratinocytes (Ellisen et al., 2002) , we tested the involvement of p63 in hypoxia-dependent induction of REDD1 by comparing CoCl 2 -induced REDD1 expression in PC-3 cells and in immortalized human keratinocytes (HaCaT cells) (Boukamp et al., 1988) . Both cell lines exhibited a sharp increase in HIF-1a protein level and also in REDD1 expression following hypoxia induction. In contrast to HaCaT cells however, p63 protein was not detectable in PC-3 cells by immunoblot analysis (Figure 3a) . Furthermore, p63 expression itself was not influenced by hypoxia in HaCaT cells. The intact hypoxia responsiveness of REDD1 expression in PC-3 cells points to a regulation that is independent of p63. We therefore asked whether knockdown of p63 in HaCaT cells has an effect on hypoxia-induced REDD1 expression. HaCaT cells were transfected with a p63-specific GB or the corresponding mismatch and 24 h later treated with CoCl 2 . The induction of both HIF-1a and REDD1 were not affected even though p63 expression was dramatically decreased (Figure 3b ). We concluded from these data that p63 function is not required for the hypoxiadependent REDD1 upregulation.
PI 3-kinase, HIF-1a and their common downstream target REDD1 are required for invasive growth of PC-3 cells
To qualify as a bona fide drug target for cancer cell treatment, the inhibition of REDD1 expression should interfere with invasive cell growth similar to the inhibition of PI 3-kinase. PC-3 cells with decreased PI 3-kinase activity exhibit reduced growth on extracellular matrix (Czauderna et al., 2003a; Figure 1a) . To compare the effects of downregulation of PI 3-kinase, HIF-1a or REDD1, we transfected PC-3 cells with GBs directed against these targets and evaluated growth of these cells on matrigel. As shown in Figure 2d , downregulation of p110b but not of p110a led to a decrease in phosphorylation of the PI 3-kinase effector Akt. Consequently, only PC-3 cells with reduced p110b expression exhibited impaired growth on extracellular matrix, while p110a knockdown had no effect on matrigel growth (Figure 4a ) (see also Czauderna et al., 2003b; Leenders et al., 2004; Tondera et al., 2004) . To analyse whether the invasive growth of PC-3 cells is dependent on HIF-1a function, we transfected HIF-1a-specific GBs into PC-3 cells. The upregulation of HIF1a due to hypoxic conditions could be blocked efficiently in GB-treated samples (Figure 4b , right panels). Even more striking was the impaired invasive growth of PC-3 cells with reduced HIF-1a expression (Figure 4b , left panels). The control cells transfected with corresponding mismatches formed the typical network structures of untreated PC-3 cells.
At this point we asked whether knockdown of REDD1 itself is sufficient for inhibition of invasive cell growth of PC-3 cells in the matrigel assay. We observed a dramatically reduced ability of PC-3 cells to grow on matrigel with both REDD1-specific GBs (Figure 4c ) similar to cells with inhibition of PI 3-kinase using LY or p110b-specific GBs (Figures 1a and 4a) . To demonstrate REDD1 inhibition in the GB-transfected cells, we analysed lysates of CoCl 2 -treated cells in parallel (Figure 4c, right panel) . Taken together, these data indicate that REDD1 is not only a downstream target of PI 3-kinase/HIF-1 signaling, but that its function is required for invasive PC-3 cell growth in vitro. To analyse the requirement of REDD1 function in vivo, we performed long-term loss of function studies using a vector-derived expression system for RNA interference (Czauderna et al., 2003a) . PC-3 cell populations stably expressing short hairpin RNAs (shRNA) specific for p110a, p110b and REDD1 were established and the proliferation of these cell pools was tested in 2D and 3D cell culture systems. In the normoxic 2D system (tissue culture plastic), we observed no differences in growth indicating similar proliferation rates of the three stable cell pools (Figure 5a ). However, as expected from the transient knockdown studies shown above, the REDD1-shRNA-and the p110b-shRNA-expressing cell populations exhibited impaired growth on extracellular matrix (Figure 5a, lower panel) . We verified the corresponding protein knockdowns by immunoblotting using wholecell lysates of these cell pools (Figure 5b) . A significant decrease in Akt phosphorylation indicative for inhibition of PI 3-kinase signaling was observed in the p110b-shRNA cell pools, but not in the p110a-shRNA or REDD1-shRNA cell pools (Figure 5b, lanes 1-3) . All three stable cell pools showed an upregulation of HIF1a protein due to CoCl 2 treatment, but only the p110a-shRNA-expressing cells were capable of inducing REDD1 (Figure 5b, lane 6 ). This result shows that the hypoxia-dependent expression of REDD1 is impaired in the stable cell pools expressing p110b-shRNAs and REDD1-shRNAs. Furthermore, inhibition of p110b expression in PC-3 cells does not effect the hypoxiainduced HIF-1a stabilization directly (Figure 5b , compare lanes 6, 9 and 12). To test the stable PC-3 cell pools for their ability to grow in vivo, we transplanted 2 Â 10 6 cells intraprostatically into nude mice (Stephenson et al., 1992; Czauderna et al., 2003a) . After 56 days, the mice were killed and analysed for primary tumor formation and lymph node metastasis. Only PC-3 cells with a reduced ability to induce REDD1 expression, namely the p110b and REDD1 shRNA-expressing cell pools, showed significantly impaired tumor growth and formation of lymph node metastasis in this orthotopic mouse tumor model (Figure 5c ). From these data together with the results obtained from the transient knockdown studies we conclude that REDD1 function is required for invasive growth of PC-3 cells in vitro and in vivo.
REDD1 function is necessary and sufficient to mediate the hypoxia-induced antiapoptotic program
To explain the requirement of REDD1 for malignant growth, we hypothesized that REDD1 may function as an antiapoptotic factor downstream of PI 3-kinase and HIF-1 signaling. To verify this, we analysed the functional role of REDD1 in HaCaT cells, since these cells do respond to various apoptotic stimuli (Boukamp et al., 1988; Mudgil et al., 2003) . Both REDD1 and HIF-1a expression in these cells were induced by CoCl 2 Figure 4 Loss of function of HIF-1a and REDD1 reduces invasive cell growth similar to inhibition of PI 3-kinase. (a) PC-3 cells were transfected in duplicate samples with antisense molecules directed against p110a or p110b as indicated (60 nM GB, or MM). To analyse the invasive growth potential, one set was seeded on matrigel 48 h post-transfection (150 000 cells in 24 wells, size bars: 500 mm) and grown for an additional 72 h. To control for efficient knockdown, a second set of transfected PC-3 cells (48 h post-transfection) was treated with CoCl 2 (100 mM) for an additional 24 h and analysed by immunoblotting using the indicated antibodies. Similarly, PC-3 cells were transfected with GBs specific for HIF-1a (b) and REDD1 (c) treatment for 24 h, whereas prolonged hypoxic conditions resulted in a dramatic decrease of REDD1 expression, despite the fact that HIF-1a expression was still high (Figure 6a ). Cleaved PARP indicating the onset of apoptosis (Soldani and Scovassi, 2002) was observed only after the REDD1 expression had declined completely (Figure 6a, left panel) . To test whether REDD1 expression is generally reduced during the onset of apoptosis, we treated HaCaT cells with different apoptotic stimuli. Both tumor necrosis factor-a (TNF-a) as well as UV-B treatment resulted in a rapid downregulation of REDD1 followed by the induction of apoptosis in these cells (Figure 6a , middle and right panel). This suggests that the presence of REDD1 protein and the onset of apoptosis are mutually exclusive in human keratinocytes. To check, whether an increased REDD1 level may protect HaCaT cells against apoptotic stimuli, we induced the REDD1 expression by CoCl 2 and compared the onset of UVinduced apoptosis (Figure 6b ). Induction of hypoxia increased HIF-1a accompanied by elevated REDD1 expression (Figure 6b , compare lanes 9 and 10). The Furthermore, direct inhibition of p63 expression did not affect hypoxia induction of REDD1 in HaCaT cells (see Figure 3) . Nevertheless, the comparison of hypoxic and nonhypoxic HaCaT cells showed a substantial increase REDD1 is required for malignant prostate cancer cell growth R Schwarzer et al in resistance to UV-induced apoptosis in hypoxic cells (Figure 6b) . Cleaved PARP signals were observed only at significant higher UV-B doses in cells with elevated levels of REDD1 expression (Figure 6b, compare lanes 5, 6, 7 with 13, 14, 15) . To test more directly whether this antiapoptotic effect is a consequence of increased REDD1 expression, we overexpressed full-length and truncated versions of REDD1 cDNA in HeLa cells before UV-B treatment. We expressed p110*, a constitutively active form of PI 3-kinase (Klippel et al., 1996) , which has been shown to mediate a survival response (Kulik et al., 1997) as a positive control. Cells expressing full-length REDD1, a C-terminally truncated version of REDD1 or constitutively active PI 3-kinase (p110*) were more resistant to UV-induced apoptosis as indicated by a reduced cleaved PARP signal compared to cells expressing a catalytically inactive mutant of p110 (K to R) or a N-terminally truncated version of REDD1 (Figure 6c ). These data suggest that increased REDD1 expression is sufficient for mediating the known hypoxia-induced antiapoptotic response (Piret et al., 2002a (Piret et al., , 2004 Zhang et al., 2003) . To test whether loss of HIF-1a or REDD1 function sensitizes cells to UVinduced apoptosis we transfected HaCaT cells with HIF-1a or REDD1-specific GBs. As shown above, hypoxic HaCaT cells were more resistant to UV treatment (Figure 6d , compare cleaved PARP signal in lanes 1 and 2). However, this protective effect was completely abolished in cells lacking REDD1 or HIF-1a expression (Figure 6d , see cleaved PARP signal in lanes 3 and 5). Since the loss of function phenotypes of HIF1a and REDD1 were indistinguishable with respect to hypoxia-mediated tolerance to apoptosis, it was not surprising that inhibition of REDD1 and HIF-1a had similar inhibitory effects on PC-3 growth on extracellular matrix (see Figure 4 ).
Discussion
REDD1 has been shown to be upregulated in response to different stress stimuli, including DNA-damaging agents and hypoxia (Ellisen et al., 2002; Shoshani et al., 2002) . Here, we provide evidence that hypoxia-induced REDD1 expression is dependent on HIF-1 and PI 3-kinase activity in PC-3 cells. While inhibition of PI 3-kinase using LY or antisense molecules does not affect the expression level of HIF-1a directly, REDD1 expression is drastically reduced (Figures 1c and 2b) . Nevertheless, hypoxia-dependent REDD1 expression requires the presence of HIF-1a (Figure 2f ). HIF-1a itself has been described to be PI 3-kinase dependently induced (Jiang et al., 2001; Hudson et al., 2002; Bardos et al., 2004; Zhou et al., 2004) , while PI 3-kinaseindependent HIF-1a stabilization by hypoxia has been reported as well (Alvarez-Tejado et al., 2002; Arsham et al., 2002; Yim et al., 2003) . For that reason it has been suggested that growth factor-induced signaling regulates HIF-1a expression via the PI 3-kinase/AKT pathway, whereas hypoxia appears to stabilize HIF-1a directly and independently of PI 3-kinase (Semenza, 2002; Paul et al., 2004) . Our experiments clearly demonstrate that even though PI 3-kinase activity is not necessary for the stabilization of HIF-1a in hypoxic PC-3 cells, it is still absolutely required for REDD1 expression. This suggests that REDD1 expression is dependent on PI 3-kinase and can be further induced by hypoxia in a HIF1a-dependent manner.
REDD1 function has been implicated in the regulation of cellular reactive oxygen species (ROS), a pathway linked both to modulation of growth factor signaling and stress responses (Adler et al., 1999; Finkel, 2000; Ellisen et al., 2002; Shoshani et al., 2002) . However, the molecular mechanism by which REDD1 modulates intracellular ROS levels is currently unknown. Ectopic expression of REDD1 inhibits in vitro differentiation and plays a role in the p53-dependent DNA damage response (Ellisen et al., 2002) . Under conditions of oxidative or ischemic stress, REDD1 can function as a pro-or antiapoptotic factor depending on the cellular context (Shoshani et al., 2002) . Here, we provide evidence for an antiapoptotic role of REDD1 using two different cell types, PC-3 prostate cancer cells and HaCaT keratinocytes. One might speculate that the p53/p63 status, and/or the differentiation status or the degree of transformation can modulate the REDD1-dependent response to apoptotic stimuli. At least in HaCaT cells it appears that downregulation of REDD1 is a prerequisite for UV-induced apoptosis, while p63 protein levels remain constant (Figure 6a ). This observation raised the question whether it is mandatory for the cell to downregulate REDD1 in order to start the apoptotic program. If so, this would in turn suggest that upregulation of REDD1 may protect cells from apoptosis. Indeed, hypoxic preconditioning desensitized human keratinocytes to UV-induced apoptosis and this protection could be abolished by downregulating either HIF-1a or REDD1 (Figure 6b, d) . Furthermore, overexpression of REDD1 under normoxic conditions protected cells from UV-induced cell death as well (Figure 6c ). Even though both pro-and antiapoptotic effects of hypoxia and HIF-1a are described (Piret et al., 2002b) , it is known that hypoxia (or induction of HIF-1a by CoCl 2 ) can reduce the sensitivity of cells to apoptosis (Piret et al., 2002a (Piret et al., , 2004 . Similarly, overexpression of HIF-1a was shown to increase cellular resistance to apoptosis (Akakura et al., 2001) . In this regard, REDD1 emerges as a novel antiapoptotic factor and as a mediator of the protective effect of hypoxic preconditioning. Hypoxia is not only protecting cells in vitro but acute hypoxia is also known for increasing the aggressiveness of tumor cells . Taken together, these data lead to the hypothesis that REDD1 can act as a survival factor promoted by PI 3-kinase as well as by HIF-1a. In any case, the possibility that differentiated and undifferentiated cells do respond differently to stress signals in a REDD1-dependent manner is an attractive hypothesis and needs further investigation.
Chronic activation of the PI 3-kinase pathway due to loss of tumor suppressor PTEN as well as overexpression of HIF-1a are frequent events in many human cancers (Cantley and Neel, 1999; Zhong et al., 1999; Di Cristofano and Pandolfi, 2000; Simpson and Parsons, 2001; Harris, 2002) . Our initial goal was to identify novel downstream targets of the PI 3-kinase pathway and to test their functional role in the invasive behavior of PC-3 cancer cells. Our loss of function analysis demonstrates that cells with reduced PI 3-kinase-, HIF-1a-or REDD1 levels exhibit a drastically decreased ability to grow on matrigel. The effects of loss of one of these factors were indistinguishable with respect to the invasive potential of PC-3 cells. The in vivo data presented using a recombinant RNA interference approach confirmed these data by showing a marked reduction in tumor formation of PC-3 cells with reduced levels of p110b and REDD1 (Figure 5c ). These results implicate not only that REDD1 is regulated at the interface of PI 3-kinase and HIF-1 signaling but also that it constitutes a critical and functionally required, downstream effector molecule of these pathways. Interestingly, a recent publication provided evidence that both PI 3-kinase/Akt and HIF1a can also promote tumor growth independently of each other (Arsham et al., 2004) . Consistent with the loss of HIF-1a function phenotype are recent attempts to identify inhibitors and to test their efficacy as anticancer therapeutics Semenza, 2003) . Taken together, our results establish REDD1 as an integrating downstream effector of PI 3-kinase and HIF-1-dependent survival programs, which are important prerequisites for invasive tumor growth. Consequently, inhibition of REDD1 function is one option to sensitize cancer cells to hypoxia and other apoptotic stimuli.
Materials and methods
Cell culture and generation of stable cell pools
Human prostate carcinoma PC-3 and Hela cells (American Type Culture Collection) were cultured as described (Czauderna et al., 2003a) . Human keratinocytes (HaCaT) were obtained from P Boukamp (DKFZ, Heidelberg, Germany) and cultured as described (Boukamp et al., 1988) . Genebloc transfections were carried out in 10-cm plates (30-50% confluency) as described by (Czauderna et al., 2003a; Kretschmer et al., 2003) . Briefly, GeneBlocs (GBs) were transfected by adding a preformed Â 10 concentrated complex of GB and lipid in serum-free medium to cells in complete medium. The total transfection volume was 10 ml. The final lipid concentration was 1.0 mg/ml; the final GB concentration was 60 nM unless otherwise stated. Plasmids were transfected using Effectenet transfection reagent (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Induction of the hypoxic responses was carried out by adding CoCl 2 (100 mM) directly to the tissue culture medium.
To assay cell growth on matrigel matrix, PC-3 cells were transfected with GBs (Sternberger et al., 2002) or treated with 10 mM LY294002 (Calbiochem) or 20 nM Rapamycin (in DMSO) for 72 h. After trypsinization, the cells were seeded in duplicates on 24-well plates (150 000 cells per well) precoated with 250 ml matrigel basement membrane matrix (Becton Dickinson, Mountain View, CA, USA). After 48 h, photographs were taken at Â 5 magnification with an Axiocam camera attached to an Axiovert S100 microscope (Zeiss, Oberkochem, Germany).
To induce apoptosis, cells were washed twice in PBS, exposed to 50 mJ/cm 2 UV-B radiation in 5 ml PBS using the UVB 500 UV crosslinker (Hoefer Scientific Instruments, San Francisco, CA, USA). After irradiation, PBS was replaced with 10 ml fresh medium. For TNFa-induced apoptosis, cells were incubated with 10 ng/ml TNFa ( þ 10 mg/ml Cycloheximide -CHX) for 2 h.
The shRNA expression plasmids were transfected with Effectene transfection reagent (Qiagen). The cells were trypsinized 48 h after transfection and seeded into selective medium. PC-3 cells stably expressing siRNA were established by selection with medium containing geneticin (600 mg/ml; Invitrogen). The medium was renewed every 3 days. After 2 weeks resistant colonies (a minimum of 200 individual clones) were trypsinized, combined in pools and cultured in selective medium.
Preparations of cell extracts and immunoblotting
The preparation of cell extracts and immunoblot analysis were carried out essentially as described (Klippel et al., 1998) . Polyclonal antibodies against full-length REDD1 were generated by immunizing rabbits with recombinant REDD1 protein produced in bacteria from pET19-b expression vector (Merck Biosciences GmbH, Schwalbach, Germany). The murine monoclonal anti-p110a and anti-p85 antibodies have been described (Klippel et al., 1998) . Rabbit polyclonal antiAkt and anti-phospho Akt (S473) antibodies, as well as polyclonal antibodies specific for cleaved PARP were obtained from Cell Signaling Technology (Beverly, MA, USA). The murine monoclonal anti-HSP60 antibody was purchased from BD Transduction Laboratories (San Diego, CA, USA). The rabbit polyclonal anti-p110b antibody and the murine monoclonal anti-p63 antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal anti-HIF-1a was purchased from R&D Systems (Minneapolis, MN, USA).
Plasmids and antisense oligonucleotides (GBs)
Expression vectors for constitutively active PI 3-kinase (p110*) and its kinase-defective control (p110-KR) have been described (Klippel et al., 1996; Kulik et al., 1997) . The coding region of the REDD1 gene was amplified by PCR using genespecific primers (REDD1 forward: 5 0 -CT TCT AGA ATG GCT CAT ATG CCT AGC CTT TGG GAC CGC TTC-3 0 and REDD1 reverse: 5 0 -AT GGA TCC TCA GGC GCC CCC ACA CTC CTC AAT GAG CAG CTG TTC-3 0 ) and the Expand Long Template PCR System kit (Roche, Mannheim, Germany). The truncated versions (shortened by 33 amino acids at either the N-or C-terminus) were generated using REDD1-DN33 forward: CT TCT AGA ATG GCT CAT TGG GGG TCG GCG ACC CGG GAG þ REDD1 reverse; REDD1 forward þ REDD1-DC33 reverse: AT GGA TCC TCA GGC GCC CCC GAA GGG AGA GTT GGC GGA GCT. The amplified product was inserted into the pCR4-TOPO cloning vector (Invitrogen, Carlsbad, CA, USA). HAtagged REDD1 expression constructs were generated by subcloning the REDD1-cDNA into pCG-HA (XbaI/BamHI) for N-terminal HA-fusion.
The used GBs represent the third generation of gapmer antisense oligonucleotides and have the following schematic structure: cap-nnnnnnNNNNNNNNnnnnnn-cap. Cap represents inverted deoxy-abasic modifications, n stands for 2 0 -Omethyl ribonucleotides (A, G, U, C) and N represents phosphorothioate-linked deoxyribonucleotides (A, G, T, C). The GBs used in the study have the following sequences: GB p110a acuccaaAGCCTCTTGcucaguu; MM p110a acugcaaACCCTGTTGcucacuu; GB p110b ggcuaacTTCATCTTCcuuccca; MM p110b ggcuaagTTCTTCATCcuugcca; GB Akt 1 gucuugATGTACTCCccucgu; MM Akt 1 guguugATCTAGTCCccuccu; GB Akt 2 uccuugTACCCAATGaaggag; MM Akt 2 uaguugTAGCCAATCaacgag; GB1 REDD1 cccaaaAGTTCAGTCgucucu; MM1 REDD1 ccgaaaAGAACAGTGcucucu; GB2 REDD1 gcuccuGCCTCTAGTcuccac; MM2 REDD1 gcucguCCCTGTAGTguccac;
GB1 HIF-1a gguaguGGTGGCATTagcagu; MM1 HIF-1a gguagaGGTGCCAATugcagu;
GB2 HIF-1a ugacucCTTTTCCTGcucugu; MM2 HIF-1a ugacacCTATACCTGcacugu; GB p63 ccauguGTGTTCTGAcgaaac; MM p63 ccaugaGTGTACTCAcguaac;
The respective mismatch positions in the mismatch control oligomeres (MM) are underlined.
Construction of shRNA expression plasmids
The pol III promoter cassettes U6 þ 2 was PCR generated using synthetical oligonucleotides and cloned into an EcoRI/XhoI restriction site of a pUC-derived vector. The specific siRNA insert was cloned using a nonpalindromic restriction enzyme (BsmBI with 5 0 overhang TTTT, 3 0 overhang GGCA). Inserts were generated by annealing two synthetic oligonucleotides with 5 0 -CCGT and 3 0 -AAAA overhangs. Generation of shRNA expression plasmids specific for p110a and p110b was described in (Czauderna et al., 2003a) . Oligonucleotides for REDD1-specific shRNA plasmid are: fwd: ccgt gtg gag act aga ggc agg agc aaa aaa aaa aaa gct cct gcc tct agt ctc cac, rev: aaaa gtg gag act aga ggc agg agc aaa aaa aaa aaa gct cct gcc tct agt ctc cac.
Oligonucleotide array expression analysis
RNA expression analysis was carried out as described (Kretschmer et al., 2003) .
Immunohistochemistry
The human prostate cancer samples were kindly provided by A Wellmann (University Bonn, Germany). The immunohistochemical analysis was performed on paraffin sections as described before (Leenders et al., 2004) . The REDD1 antiserum or preimmune serum were used at 1 : 5000 dilution.
Orthotopic prostate tumor/metastasis model
Male Shoe:NMRI-nu/nu mice (DIMED, Germany) 8-week old were inoculated with 2 Â 10 6 stably transfected PC-3 cells into the left dorsolateral lobe of the prostate gland under total body anesthesia. Each group consisted of eight mice. Animals were killed 56 days postoperation and tumors (prostate gland), regional metastases (caudal, lumbar and renal lymph node metastases) and distant metastases were measured in two dimensions by means of a pair of calipers and the volume was calculated according to V(mm 3 ) ¼ ab 2 /2 with boa. All killed animals were completely dissected and photographically documented. The mouse experiments (mouse surgery, cell transplantation, measurement of tumor volume, etc.) were performed double blind and independently by two researchers.
